Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cipher Pharmaceuticals Inc

+ Add to Watchlist

PHE:GR

8.893 EUR 0.167 1.84%

As of 07:05:48 ET on 05/22/2015.

Snapshot for Cipher Pharmaceuticals Inc (PHE)

Open: 8.943 Day's Range: 8.893 - 8.943 Volume: 0
Previous Close: 9.060 52wk Range: 5.049 - 13.450 1-Yr Rtn: +76.13%

Stock Chart for PHE

No chart data available.
  • PHE:GR 8.893
  • 1M
  • 1Y
9.060
Interactive PHE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHE

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 27.3708
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2015) 0.4430
Est. PEG Ratio -
Market Cap (M EUR) 230.26
Shares Outstanding (M) 25.89
30 Day Average Volume 82
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHE

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for PHE

Cipher Pharmaceuticals Inc. is involved in the licensing, clinical development, and regulatory approval of prescription medications utilizing drug delivery technologies or new pharmaceuticals. The Company also conducts clinical trials, regulatory affairs services, and statistical analysis for the pharmaceutical, biotechnology, and medical devices industries.

Shawn Patrick O'BrienPresident/CEONorman EvansCFO/Secretary
Joan ChypyhaVP:Marketing & SalesJason D GrossVP:Scientific Affairs
More Company Profile & Key Executives for PHE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil